Granulocyte Colony-Stimulating Factor Prevents Reperfusion Injury After Heart Preservation

Annals of Thoracic Surgery

Volumn 85, Issue 4, 2008, Pages 1367-1373

  Higuchi, Takuya ^a   Yamauchi Takihara, Keiko ^a   Matsumiya, Goro ^a   Fukushima, Norihide ^a   Ichikawa, Hajime ^a   Kuratani, Toru ^a   Maehata, Yoshito ^a   Sawa, Yoshiki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; GRANULOCYTE COLONY STIMULATING FACTOR; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN BAX; PROTEIN BCL XL; SODIUM CHLORIDE; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CRYOPRESERVATION; DOSE RESPONSE; ENZYME PHOSPHORYLATION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PRESERVATION; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; ISOLATED HEART; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEART FUNCTION TESTS; HEART TRANSPLANTATION; HEMODYNAMICS; HYPOTHERMIA, INDUCED; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; ISCHEMIC PRECONDITIONING; MALE; MYOCARDIAL REPERFUSION INJURY; ORGAN PRESERVATION; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TYRPHOSTINS;

EID: 40749104205     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.12.053     Document Type: Article

References (24)

1. + exchange inhibition improves long-term myocardial preservation. Ann Thorac Surg 66 (1998) 436-442
2. Jahania M.S., Sanchez J.A., Narayan P., Lasley R.D., and Mentzer R.M. Heart preservation for transplantation: principles and strategies. Ann Thorac Surg 68 (1999) 1983-1987
3. Masters T.N., Fokin A.A., Schaper J., Lorenz-Meyer S., Pool L., Gong G., et al. Extending myocardial viability during heart preservation with cyclosporine A. J Card Surg 15 (2000) 392-402
4. Ryugo M., Sawa Y., Ono M., Fukushima N., Aleshin A.N., Mizuno S., et al. Myocaedial protective effect of human recombinant hepatocyte growth factor for prolonged heart graft preservation in rats. Transplantation 78 (2004) 1153-1158
5. Oriyanhan W., Yamazaki K., Miwa S., Takaba K., Ikeda T., and Komeda M. Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation. Heart Vessels 20 (2005) 278-285
6. Fukushima N., Shirakura R., Nakata S., Kaneko M., Miyagawa S., Naka Y., et al. Study of efficacies of leukocyte-depleted terminal blood cardioplegia in 24-hour preserved hearts. Ann Thorac Surg 58 (1994) 1651-1656
7. Berliner N., Hsing A., Graubert T., Sigurdsson F., Zain M., Buruno E., et al. Granulocyte colony-stimulating factor induction of normal human bone marrow progenitors results in neutrophil-specific gene expression. Blood 85 (1995) 799-803
8. Harada M., Qin Y., Takano H., Minamino T., Zou Y., Toko H., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 11 (2005) 305-311
9. Minatoguchi S., Takemura G., Chen X.H., Wang N., Uno Y., koda M., et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109 (2004) 2572-2580
10. Iwanaga K., Takano H., Ohtsuka M., Hasegawa H., Zou Y., Qin Y., et al. Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem Biophys Res Commun 325 (2004) 1353-1359
11. Hilfiler-Kleiner D., Hilfiker A., and Drexler H. Many good reasons to have STAT3 in the heart. Pharmacol Ther 107 (2005) 131-137
12. Ibrahim M., Masters R.G., Hendry P.J., Davies R.A., Smith S., Struthers S., et al. Determinants of hospital survival after cardiac transplantation. Ann Thorac Surg 59 (1995) 604-608
13. Hosenpud J.D., Bennett L.E., Keck B., Fiol B., and Novick R.J. The registry of the International Society for Heart and Lung transplantation: fourteenth official report-1997. J Heart Lung Transplant 16 (1997) 691-712
14. Belzer F.O., and Southard J.H. Principles of solid organ preservation by cold overview. Transplantation 45 (1988) 673-676
15. Kunisada K., Negoro S., Tone E., Funamoto M., Osugi T., Yamada S., et al. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci USA 97 (1999) 315-319
16. Smith R.M., Suleman N., Lacerda L., Opie L.H., Akira S., Chien K.R., et al. Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning. Cardiovasc Res 63 (2004) 611-616
17. Bolli R., Dawn B., and Xuan Y.T. Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc Med 13 (2003) 72-79
18. Hilfiker-Kleiner D., Hilfiker A., Fuchs M., Schaefer A., Schieffer B., hillmer A., et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, heart protection from ischemic injury. Cir Res 95 (2004) 187-195
19. Podewski E.K., Hilfiker-Kleiner D., Hilfiker A., Morawietz H., Lichtenberg A., Wollert K.C., et al. Alterations in Janus Kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation 107 (2003) 798-802
20. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
21. Deindle E., Zaruba M.M., Brunner S., Huber B., Mehl U., Assmann G., et al. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J 20 (2006) E27-E36
22. Falzetti F., Aversa F., Minelli O., and Tabilio A. Spontaneous rupture of spleen during peripheral blood stem-cell mobilization in a healthy donor. Lancet 353 (1999) 5
23. Becker P.S., Wagle M., Matous S., Swanson R.S., Pihan G., lowry P.A., et al. Spontaneous splenic repture following administration of granulocyte colony-stimulating factor (G-CSF): Occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplantation 3 (1997) 45-49
24. Logue S.E., Gustafasson A.B., Samali A., and Gottlie b R.A. Ischemia/reperfusion injury at the interaction with cell death. J Mol Cell Cardiol 38 (2005) 21-33